Publications

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface

Domínguez-Medina CC. et al, (2020), Nature Communications, 11

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.

Micoli F. et al, (2020), Proceedings of the National Academy of Sciences of the United States of America, 117, 24443 - 24449

Outer membrane vesicle vaccines

Micoli F. and MacLennan CA., (2020), Seminars in Immunology, 50, 101433 - 101433

Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?

Steele AD. et al, (2020), Clinical Infectious Diseases, 71, S185 - S190

Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019

Gottlieb SL. et al, (2020), Vaccine, 38, 4362 - 4373

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints

MacLennan CA. et al, (2019), Clinical Infectious Diseases, 69, S591 - S595

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview

MacLennan CA. et al, (2019), Clinical Infectious Diseases, 69, S577 - S579

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays.

Kaminski RW. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S596 - S601

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies.

Talaat KR. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S580 - S590

The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.

Park SE. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S422 - S434

Genomic characterization of novel Neisseria species.

Diallo K. et al, (2019), Scientific reports, 9

How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?

Giersing BK. et al, (2019), Vaccine, 37, 4778 - 4783

Cross-sectional study of IgG antibody levels to invasive nontyphoidal Salmonella LPS O-antigen with age in Uganda

Stockdale L. et al, (2019), Gates Open Research, 3, 1501 - 1501

Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway.

Benedikz EK. et al, (2019), Scientific reports, 9

Rapid transcriptional responses to serum exposure are associated with sensitivity and resistance to antibody-mediated complement killing in invasive Salmonella Typhimurium ST313

Ondari EM. et al, (2019), Wellcome Open Research, 4, 74 - 74